InspireMD Inc. NSPR 深 沪
等待开盘 03-26 09:30:00 美东时间
1.76
-0.030
-1.68%
华盛通- 最 高1.79
- 今 开1.78
- 成交量 1.49万股
- 最 低 1.75
- 昨 收 1.79
- 总市值 7457.30万
- 52周最高 2.9319
- 市盈率 静 --
- 换手率 0.04%
- 52周最低 1.51
- 委 比 -38.08%
- 总股本 4237.10万
- 历史最高 27890625.00
- 量 比 0.21
- 振 幅 2.23%
- 历史最低 0.806
- 每 手 1
- 风险率 0.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BUZZ-InspireMD rises after quarterly revenue beat
BUZZ-InspireMD rises after quarterly revenue beat ** Shares of medical device maker InspireMD NSPR.O rise 10.61% to $1.98 ** Co posts Q4 revenue of $3.1 million, above analysts' average estimate of $2.6 million, according to data compiled by LSEG ** Says quarterly revenue rose on early U.S. uptake o
03-18 21:40
InspireMD shares are trading higher after the company reported better-than-expected Q4 financial results.
InspireMD shares are trading higher after the company reported better-than-expe...
03-18 21:05
InspireMD Q4 revenue rises 62%, beats estimates
InspireMD Q4 revenue rises 62%, beats estimates Overview Carotid stent developer's Q4 revenue grew 62% yr/yr, beating analyst expectations Q4 operating loss and net loss were lower than analysts' forecasts Revenue growth driven by U.S. launch of CGuard Prime and rising international demand Outlook I
03-18 19:13
Earnings Scheduled For March 18, 2026
Companies Reporting Before The Bell • SailPoint (NASDAQ:SAIL) is estimated to r...
03-18 19:11
InspireMD Sees FY2026 Sales $13.000M-$15.000M vs $14.553M Est
InspireMD (NASDAQ:NSPR) sees FY2026 sales of $13.000 million-$15.000 million vs $14.553 million analyst estimate.
03-18 19:06
InspireMD Q4 revenue rose 62% to USD 3.15 million, net loss widened to USD 11.76 million
InspireMD Q4 revenue rose 62% to USD 3.15 million, net loss widened to USD 11.76 million InspireMD published a quarterly and annual earnings press release reporting Q4 2025 revenue of USD 3.15 million, up 62% year-over-year. Q4 2025 gross profit was USD 1.18 million and net loss was USD 11.76 millio
03-18 19:04
InspireMD Q4 EPS $(0.14) Beats $(0.19) Estimate, Sales $3.149M Beat $2.626M Estimate
InspireMD (NASDAQ:NSPR) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.19) by 27.46 percent. This is a 26.32 percent increase over losses of $(0.19) per share from the
03-18 19:02
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
InspireMD, Inc. will release its fourth quarter and full year 2025 financial results on March 18, 2026, and host a conference call and webcast at 8:30 a.m. ET to discuss its financial results and recent highlights. A live audio webcast and archives will be available on the Investors page of InspireMD’s website. Interested participants should register 15 minutes before the call.
03-09 13:00
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD, Inc. announced that its Compensation Committee approved inducement grants of 36,118 restricted shares to one new non-executive employee, outside its 2021 Equity Incentive Plan, under the 2024 Inducement Plan. The shares vest over three years, with one-third vesting annually. The grants comply with Nasdaq Listing Rule 5635(c)(4).
01-20 14:00
InspireMD Publishes Data From Its C-GUARDIANS Pivotal Study Journal Of The American College of Cardiology
InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that results from the Company's C-GUARDIANS pivotal
01-12 22:03
